LSP closes European record $600m fund for life sciences
In further positive signs for the European biotech market, LSP exceeds its funding target to raise largest ever sum in Europe.
In further positive signs for the European biotech market, LSP exceeds its funding target to raise largest ever sum in Europe.
Amicus announces the opening of a gene therapy center that has been established in partnership with the University of Pennsylvania.
Following on from European approval, Pharming announces the US FDA has approved its new facility for the production of its Ruconest product.
Bifidobacteria can accumulate in tumours and improve the efficacy of cancer treatment, according to a new study in mice.